李燕嫦　歐婉燕　劉國(guó)江　張曉輝　陳威

[摘要] 目的 探討高頻超聲聯(lián)合SPECT應(yīng)用于甲狀腺癌診斷中的臨床價(jià)值。方法 方便選取2017年6月—2018年6月該院收治97例甲狀腺腫瘤患者作為研究對(duì)象，全部患者均進(jìn)行高頻超聲檢查，并聯(lián)合SPECT檢查進(jìn)行診斷，將術(shù)后病理學(xué)結(jié)果作為“金標(biāo)準(zhǔn)”，分析高頻超聲聯(lián)合SPECT應(yīng)用于甲狀腺癌診斷中的臨床價(jià)值。結(jié)果 經(jīng)手術(shù)及病理證實(shí)，97例患者中良性腫瘤51例，約占52.58%;惡性腫瘤46例，約占47.42%。高頻超聲聯(lián)合SPECT組檢出良性腫瘤50例、惡性腫瘤45例，診斷準(zhǔn)確率為97.94%;高頻超聲組檢出良性腫瘤46例，惡性腫瘤42例，診斷準(zhǔn)確率為90.72%。兩組比較差異有統(tǒng)計(jì)學(xué)意義（P<0.05）;高頻超聲聯(lián)合SPECT組無(wú)誤診情況發(fā)生，共2例漏診，漏診率2.06%;高頻超聲組1例誤診，誤診率1.03%，8例漏診，漏診率8.25%，差異有統(tǒng)計(jì)學(xué)意義（P<0.05）。結(jié)論 將高頻超聲、SPECT檢查聯(lián)合應(yīng)用于甲狀腺癌診斷中具有重要臨床價(jià)值，可進(jìn)一步提高診斷準(zhǔn)確率，為疾病治療工作的開(kāi)展及預(yù)后評(píng)估提供可靠影像學(xué)依據(jù)。

[關(guān)鍵詞] 高頻超聲;SPECT;甲狀腺癌;良性腫瘤;惡性腫瘤;診斷準(zhǔn)確率

[中圖分類(lèi)號(hào)] R5? ? ? ? ? [文獻(xiàn)標(biāo)識(shí)碼] A? ? ? ? ? [文章編號(hào)] 1674-0742（2019）05（a）-0183-03

[Abstract] Objective To investigate the clinical value of high frequency ultrasound combined with SPECT in the diagnosis of thyroid cancer. Methods A total of 97 patients with thyroid cancer admitted to our hospital from June 2017 to June 2018 were convenient selected. All patients underwent high-frequency ultrasound examination and SPECT examination for diagnosis. The pathological results after operation were regarded as "gold standard". The clinical value of high-frequency ultrasound combined with SPECT in the diagnosis of thyroid cancer was analyzed. Results Surgery and pathology confirmed that 51 cases of benign tumors accounted for 52.58% and 46 cases of malignant tumors accounted for 47.42%. Fifty cases of benign tumors and 45 cases of malignant tumors were detected by high-frequency ultrasound combined with SPECT， the diagnostic accuracy was 97.94%. And 46 cases of benign tumors and 42 cases of malignant tumors were detected by high-frequency ultrasound combined with SPECT， the diagnostic accuracy was 90.72%. The difference between the two groups was statistically significant （P<0.05）. There was no misdiagnosis in the high frequency ultrasound combined with SPECT group， 2 cases were missed， the missed diagnosis rate was 2.06%. In the high frequency ultrasound group， 1 case was misdiagnosed， the misdiagnosis rate was 1.03%， 8 cases were missed， the missed diagnosis rate was 8.25%， the difference was statistically significant （P<0.05）. Conclusion The combination of high frequency ultrasound and SPECT has important clinical value in the diagnosis of thyroid cancer. It can further improve the diagnostic accuracy and provide reliable imaging basis for the development of disease treatment and prognosis evaluation.

[Key words] High frequency ultrasound; SPECT; Thyroid cancer; Benign tumors; Malignant tumors; Diagnostic accuracy